특발성 육아종성 유방염의 임상병리학적 특징, 경과 및 치료 결과
Clinicopathologic Features, Clinical Course and Outcomes of Idiopathic Granulomatous Mastitis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory breast disease that mimics breast cancer in terms of clinical and radiological finding. The treatment of IGM remains controversial. We aim to evaluate the clinicopathological feature and outcomes of IGM. Methods: Fifty five pathologically confirmed IGM patients who were treated between 2005 and 2013 were enrolled. All patients were categorized into three groups according to treatment methods: conservative care including observation, aspiration, and antibiotics; steroid; surgical intervention groups. Results: The median age at time of diagnosis was 35.8 years (range, 20–49 years). The most common chief complaints were a palpable mass (40.0%) followed by painful mass (32.7%) and pain (21.8%). Thirty-one patients were treated with antibiotics for their initial treatment. Steroid treatment was initially performed in eighteen cases. The initial steroid treatment was changed to methotrexate treatment in six patients who developed side effects, such as steroid-induced diabetes mellitus and Cushing’s syndrome or showed no response to treatment. Surgical interventions were performed in six patients as the first-line treatment. Mean time to remission was 7.2±6.9 months and 1-year recurrence-free interval was 89%. Mean time to remission in conservative care group and steroid group was 5.3±5.6 months and 11.4±7.9 months, respectively, and it was significantly different (p=0.008). Conclusion: A multidisciplinary approach including close observation, antibiotics treatment, systemic steroid, methotrexate, and surgical intervention is the currently available treatment option for IGM. IGM should be closely followed up due to the frequency of disease recurrence.
Abstract
Purpose: Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory breast disease that mimics breast cancer in terms of clinical and radiological finding. The treatment of IGM remains controversial. We aim to evaluate the clinicopathological feature and outcomes of IGM. Methods: Fifty five pathologically confirmed IGM patients who were treated between 2005 and 2013 were enrolled. All patients were categorized into three groups according to treatment methods: conservative care including observation, aspiration, and antibiotics; steroid; surgical intervention groups. Results: The median age at time of diagnosis was 35.8 years (range, 20–49 years). The most common chief complaints were a palpable mass (40.0%) followed by painful mass (32.7%) and pain (21.8%). Thirty-one patients were treated with antibiotics for their initial treatment. Steroid treatment was initially performed in eighteen cases. The initial steroid treatment was changed to methotrexate treatment in six patients who developed side effects, such as steroid-induced diabetes mellitus and Cushing’s syndrome or showed no response to treatment. Surgical interventions were performed in six patients as the first-line treatment. Mean time to remission was 7.2±6.9 months and 1-year recurrence-free interval was 89%. Mean time to remission in conservative care group and steroid group was 5.3±5.6 months and 11.4±7.9 months, respectively, and it was significantly different (p=0.008). Conclusion: A multidisciplinary approach including close observation, antibiotics treatment, systemic steroid, methotrexate, and surgical intervention is the currently available treatment option for IGM. IGM should be closely followed up due to the frequency of disease recurrence.
참고문헌 (30)
- Al-Khaffaf B, "Idiopathic granulomatous mastitis:a 25-year experience", J Am Coll Surg, 206, pp.269~273 (2008)
- Lee SD, "Diagnosis and treatment of granulomatous mastitis", J Korean Surg Soc, 58, pp.487~493 (2000)
- Akbulut S, "Is methotrexate an acceptable treatment in the management of idiopathic granulomatous mastitis?", Arch Gynecol Obstet, 284, pp.1189~1195 (2011)
- Akbulut S, "Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases", Breast J, 17, pp.661~668 (2011)
- Osborne BM, "Granulomatous mastitis caused by histoplasma and mimicking inflammatory breast carcinoma", Hum Pathol, 20, pp.47~52 (1989)
- Kessler E, "Granulomatous mastitis: a lesion clinically simulating carcinoma", Am J Clin Pathol, 58, pp.642~646 (1972)
- Cserni G, "Granulomatous Lobular Mastitis Following Drug-Induced Galactorrhea and Blunt Trauma", Breast J, 5, pp.398~403 (1999)
- 태순영, "특발성 육아종성 유방염의 수술적 치료", 대한외과학회지, 77(3), pp.153~160 (2009), 대한외과학회
- 이지현, "육아종성 유방염", 대한외과학회지, 72(2), pp.94~100 (2007), 대한외과학회
- Mizrakli T, "Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery", Surg Today (2014)
- Gunay Gurleyik, "Medical and Surgical Treatment of Idiopathic Granulomatous Lobular Mastitis: A Benign Inflammatory Disease Mimicking Invasive Carcinoma", Journal of Breast Cancer, 15(1), pp.119~123 (2012), 한국유방암학회
- Pandey TS, "Idiopathic granulomatous mastitis--a prospective study of 49 women and treatment outcomes with steroid therapy", Breast J, 20, pp.258~266 (2014)
- Erhan Y, "A clinicopthologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis", Breast, 9, pp.52~56 (2000)
- Donn W, "Idiopathic granulomatous mastitis. A report of three cases and review of the literature", Arch Pathol Lab Med, 118, pp.822~825 (1994)
- Lai EC, "The role of conservative treatment in idiopathic granulomatous mastitis", Breast J, 11, pp.454~456 (2005)
- 허성모, "Experience of treatment of patients with granulomatous lobular mastitis", 대한외과학회지, 85(1), pp.1~6 (2013), 대한외과학회
- Neel A, "Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study", QJM, 106, pp.433~441 (2013)
- 이해경, "특발성 육아종성 유방염의 진단과 치료 성적: 35예의 임상적 치험", 대한외과학회지, 71(3), pp.174~177 (2006), 대한외과학회
- Erozgen F, "Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma", Breast Cancer Res Treat, 123, pp.447~452 (2010)
- Wieck A, "Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review", Br J Psychiatry, 182, pp.199~204 (2003)
- Maurizio Bellavia, "Granulomatous Mastitis during Chronic Antidepressant Therapy: Is It Possible a Conservative Therapeutic Approach?", Journal of Breast Cancer, 15(3), pp.371~372 (2012), 한국유방암학회[DOI]
- Wilson JP, "Idiopathic granulomatous mastitis: in search of a therapeutic paradigm", Am Surg, 73, pp.798~802 (2007)
- Ayeva-Derman M, "Idiopathic granulomatous mastitis. Review of the literature illustrated by 4 cases", J Gynecol Obstet Biol Reprod (Paris), 28, pp.800~807 (1999)
- DeHertogh DA, "Prednisone management of granulomatous mastitis", N Engl J Med, 303, pp.799~800 (1980)
- Joseph KA, "Granulomatous Mastitis: a New York Public Hospital Experience", Ann Surg Oncol (2014)
- Katz U, "Chronic idiopathic granulomatous mastitis", Ann N Y Acad Sci, 1108, pp.603~608 (2007)
- Asoglu O, "Feasibility of surgical management in patients with granulomatous mastitis", Breast J, 11, pp.108~114 (2005)
- 최용호, "만성 육아종성 유방염", 대한외과학회지, 71(2), pp.90~94 (2006), 대한외과학회
- Hovanessian Larsen LJ, "Granulomatous lobular mastitis: imaging, diagnosis, and treatment", AJR Am J Roentgenol, 193, pp.574~581 (2009)
- Oran ES, "Management of idiopathic granulomatous mastitis diagnosed by core biopsy: a retrospective multicenter study", Breast J, 19, pp.411~418 (2013)